Analysis of continuous glucose tracking data in people with type 1 diabetes after COVID‐19 vaccination reveals unexpected link between immune and metabolic response, augmented by adjunctive oral medication

Introduction The COVID‐19 vaccination programme is under way worldwide. Anecdotal evidence is increasing that some people with type 1 diabetes mellitus (T1DM) experience temporary instability of blood glucose (BG) levels post‐vaccination which normally settles within 2‐3 days. We report an analysis...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of clinical practice (Esher) 2021-12, Vol.75 (12), p.e14714-n/a
Hauptverfasser:	Heald, Adrian H., Rea, Rustam, Horne, Linda, Metters, Ann, Steele, Tom, Leivesley, Kathryn, Whyte, Martin Brunel, Stedman, Mike, Ollier, William
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Blood Glucose Blood Glucose Self-Monitoring COVID-19 COVID-19 Vaccines Diabetes Diabetes mellitus (insulin dependent) Diabetes Mellitus, Type 1 - drug therapy Glucose Glucose monitoring Humans Hypoglycemia Hypoglycemic Agents Immunization Insulin Metabolic response Metformin Middle Aged Original Paper Original Papers SARS-CoV-2 Vaccination
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!